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Abstract 
Crohn’s Disease is an Inflammatory Bowel Disease (IBD) that affects up to 3 million 
Americans (Dahlhamer et al). It is a heterogeneous disease with variation in disease presentation, 
progression, and response to treatment. Genome Wide Association Studies (GWAS) discovered 
242 genomic sites that were associated with Crohn’s Disease, many of which were found in 
noncoding regions (Mirkov et al). Since there is a genetic component associated with Crohn’s 
Disease, this project aims to look at this variation in patients with Crohn’s Disease to determine 
how GWAS loci influence disease. Specifically, this project aimed to develop and apply the 
WASP computational pipeline to detect sites of allelic imbalance in sample data (van de Geijn et 
al). ATAC-seq is a functional genomics assay used to assess chromatin accessibility. Using 
ATAC-seq data, we analyze allelic imbalance in noncoding regions of the genome. Mapping bias 
was mitigated in this pipeline by representing the alternate allele in each sequencing read. Over 
150 patient samples were processed to determine sites of allelic imbalance. 10 Crohn’s Disease 
samples with the highest number of allelic imbalance sites were further analyzed to find 62 total 
sites that overlapped GWAS loci.  
  
Introduction 
Crohn’s Disease is a heterogeneous disease that can inflame different components of the 
gastrointestinal tract from the mouth to anus. Due to the variety in phenotypes, diagnosis of the 
disease can be difficult. Genetic variability and differences in the environment can result in 
variability with disease progression and response to treatment. Clinical phenotypes, however, 
have not been useful in predicting disease progression and response to treatment (Wolters et. al). 
We believe the solution to understanding the disease lies in the molecular characteristics of the 
colonic and intestinal tissue as opposed to clinical phenotypes. By understanding the molecular 
basis behind the disease, scientists can better determine progression, treatment response, and 
more. 
 After performing Genome Wide Association Studies (GWAS), 242 loci associated with 
IBD have been found (Mirkov et al). Individual variants in those loci were found largely in 
noncoding regions, which can impact gene regulatory elements. This presents a unique 
challenge, as it is difficult to determine how each variant affects gene expression. Variants in 
coding regions can directly affect gene expression by changing the amino acid sequence, 
whereas variants in noncoding regions can indirectly affect gene expression by influencing 
expression levels by affecting transcription factor binding sites. If allelic imbalance was found in 
a transcription factor binding site, one allele could result in downstream expression of the gene. 
The other allele could result in no gene expression, as the transcription factor cannot bind.  
 To identify locations of noncoding regions, we used the Assay for Transposase- 
Accessible Chromatin using sequencing (ATAC-seq) method, which maps chromatin 
accessibility genome-wide. ATAC-seq data identifies regions of open chromatin that are 
regulatory elements, and in doing so generates sequencing reads at these regions of open 
chromatin (Buenrostro et al). If a variant changes the chromatin accessibility, we can 
hypothesize that it changes the activity of that regulatory element depending on which allele is 
present.  
 The goal of this paper is looking at allelic imbalance -- a phenomenon where two 
different alleles in the genome have differential levels of chromatin accessibility (Wagner et al). 
The ATAC-seq assay generates a sequencing readout. At a heterozygous site, we can quantify 
how much of the signal from the assay comes from one allele compared to the other. If there is a 
signaling imbalance, we can conclude that there is allelic imbalance (Figure 1).  
 
Figure 1: Visualization of Allelic Imbalance with Sequencing Reads 
This diagram demonstrates allelic imbalance with sequencing reads. The genome being aligned 
to is above each line, and the sequencing reads are below. The component on the left shows the 
expected allele distribution at a heterozygous site, whereas the right component shows allelic 
imbalance at the same site.  
 
From an IBD sample, if a site has allelic imbalance in ATAC-seq data, a natural 
hypothesis is that the variant is affecting the levels of chromatin accessibility. This analysis is 
meant to provide candidate allelic imbalance sites at single nucleotide polymorphisms (SNPs) to 
be further investigated. Analysis of these allelic imbalance sites may tell us about how variation 
is affecting the overall gene regulatory program. We hypothesize that allelic imbalance analysis 
using ATAC-seq data will uncover instances of significant allelic imbalance at variants in 
non-coding regulatory regions that have been associated with CD. This will serve as the basis for 
future hypotheses as to the functional mechanism driving this association. 
In this project, we apply a robust computational pipeline that reduces mapping bias in 
allelic imbalance analysis using ATAC-seq data in noncoding regions. Mapping bias can arise 
when aligning a sequencing read to a genome. If the read does not contain the same sequence as 
that of the reference genome at a particular site, mapping can occur at a different location (Liu et 
al). This can be imprecise, as each read only represents one of the possible alleles at 
heterozygous sites. By accounting for this by mitigating mapping bias, we are reducing the 
number of reads with non-reference alleles that are not being properly mapped to their true 
location. Sample data was later applied to this pipeline to determine allelic imbalance in Crohn’s 
Disease patients. An analysis of allelic imbalance sites from 10 patients was also performed.  
 
Methods 
Patient data used in this experiment has previously been collected with IRB approval 
(study #10-0355 (Dr. Hans Herfarth PI) and #17-0236 (Dr. Shehzad Sheikh, PI)). Two patient 
groups were used in this study, those with Crohn’s Disease and those with nonIBD illnesses. All 
patients were adults diagnosed at UNC Hospitals. Colon tissue samples were taken from each 
patient. The ATAC-seq experiment was performed on 66 nonIBD samples and 103 Crohn’s 
Disease samples to generate paired-end reads in the form of fastq files. Fastq files were 
organized into three groups: nonIBD, uninflamed Crohn’s Disease colon tissue, and inflamed 
Crohn’s Disease colon tissue. Sample data was only processed from the nonIBD and uninflamed 
Crohn’s Disease colon tissue groups. Additionally, patients were genotyped using the 
ImmunoChip genotyping array, and genotypes were phased and imputed using the University of 
Michigan Server. This created SNP data in the form of variant cell format (vcf) files.  
 The WASP pipeline (van de Geijn et al) was used to perform allelic imbalance analysis 
for this project. Specifically, the mapping pipeline is used to mitigate mapping biases when 
aligning ATAC-seq reads to the genome. The output was a binary alignment map (bam) file 
which contained positional and counting data for each read. This served as an input for the 
combined haplotype test, which determined whether significant allelic imbalance was present for 
each site that had a heterozygous allele.  
 
Figure 2:​ ​Overview of WASP Mapping Pipeline and CHT Test 
 
Datasets have rounded borders, processes are rectangles. The mapping pipeline is in blue, and 





 We converted variant information in the form of HDF5 files, which are in a binary 
format. The first step used the snp2h5 script to take the vcf input and output haplotypes.h5, 
index.h5, and snp_table.h5 files. These are referred to as h5 files throughout this analysis.  
 The fastq files were mapped to the hg19 reference genome using the bowtie aligner from 
the PEPATAC ATAC-seq pipeline. The output of this alignment process was a bam file, which 
stores similar information to the fastq files, in addition to containing read position information. 
This bam file was sorted and indexed using samtools.  
 To mitigate mapping bias, reads overlapping heterozygous sites were aligned normally, 
representing the reference allele. Then, a copy of these reads was created, but represented with 
the alternate allele and realigned. Reads that aligned to the same location with both alleles were 
kept (Figure 2). This step was performed using the find_intersecting_snps.py script, where the 
inputs were the h5 files, sample name, and output directory, and the output was a pair of fastq 
files. The output pair of fastq files were then mapped to the hg19 reference genome using the 
same alignment method. Again, bowtie was used, and the output .bam file was sorted and 
indexed.  
 Reads with the alternate allele represented that failed to map to the same position were 
removed. We used filter_remapped_reads.py with the inputs as each .bam file from the genome 
alignment; the output is a keep.bam file. Afterwards, this keep.bam file was merged with the first 
bam output to create a keep.merge.bam file by using the merge function in samtools. This 
keep.merge.bam file must also be sorted and indexed using samtools. Then, duplicate reads were 
removed to avoid the double counting of reads by using the rmdup_pe.py script. The output bam 
file was sorted and indexed using samtools.  
  
Combined Haplotype Test: 
 WASP’s Combined Haplotype Test uses the output bam file from the mapping pipeline 
and the SNP data used in the mapping file in the form of a vcf file. The SNP data was first 
converted to the binary h5 format to be utilized by WASP scripts. The bam file is also converted 
to the h5 format as the read counts are extracted from the bam2h5.py script. 
 Target regions and peaks for allelic imbalance were then identified using the 
get_target_regions.py script. Given the nature of regulatory elements, region sizes in open 
chromatin can vary from small distal regions to large promoter regions. In this step, the peaks 
were identified by SNP data, and regions were set to the default of 2000 bases. Peaks required 
that at least 10 reads overlapped the heterozygous site, with at least one from each allele, and that 
at least 100 total reads were in the defined peak.  
 The input for the statistical tests were then created using the 
extract_haplotypes_read_counts.py script. This script uses the target regions and SNP peaks 
from the previous step to organize data in a new file format.  
 Read counts were adjusted after considering factors such as read depth and GC content 
and peakiness. The number of reads mapping to a target region were modelled with a 
beta-negative binomial distribution after adding overdispersion parameters for each individual 
and target region. Additionally, the Illumina sequencers which provided the fastq files as the 
input to the mapping pipeline are known to have a bias towards reads with a higher GC content. 
WASP accounts for this variability to provide an accurate representation of reads by using h5 
files to discover regions of GC-rich content.  
 Reference and alternate allele total counts were used to adjust the heterozygote 
probabilities in the statistical test input file. To avoid false positive heterozygous sites which can 
result from reads that only exhibit one allele, WASP assumes allele-specific reads follow two 
beta-binomial distributions (van de Geijn et al).  
Then, the overdispersion parameters for the allele-specific beta-binomial test and 
association beta-negative binomial tests were estimated. These steps were performed using 
WASP’s update_het_probs.py, fit_as_coefficients.py, and fit_bnb_coefficients.py scripts before 
performing a combined likelihood ratio test. This test uses the aforementioned overdispersion 
parameters to compare the null and alternative hypotheses and generate a likelihood ratio 
statistic. For each site, a p value is calculated using this statistic.  
Each of the 169 samples was processed through the mapping and CHT pipelines. Of 
these, 10 Crohn’s Disease samples with the highest number of allelic imbalance sites were 







ATAC-seq data from the uninflamed tissue of 10 Crohn’s Disease patients served as 
input to the WASP pipeline to identify specific sites of allelic imbalance. First, for each 
individual, sequencing reads from the ATAC-seq were aligned or mapped to the human 
reference genome, and reads that overlap heterozygous sites in an individual were identified. To 
remove any mapping bias, those same reads were modified to change the allele at the 
heterozygous site to the alternate allele, and then the reads were re-mapped to the genome. Only 
those reads that were mapped to the same location were retained for further analyses. These 
reads were processed using a combined haplotype test, which performed statistical analyses and 
determined sites of significant allelic imbalance in each individual.  
 
Sites of allelic imbalance in 10 Crohn’s Disease patients: 
The 10 samples each had a varying number of allelic imbalance sites. After filtering for 
sites with p < 0.05, samples contained an average of 988 sites and a standard deviation of 732 
sites. Samples ranged from having 542 to 2953 sites. Sites that had the same position across 
multiple samples were filtered to reveal 9470 unique, statistically significant sites of allelic 
imbalance in at least one sample. A comparison was done across the 10 samples to determine 
which sites were common in multiple samples. In this comparison, an exact base pair match 





Figure 3: Histogram of allelic imbalance sites overlapping multiple samples 
 
Each bar represents the number of sites that are present in the given number of samples. Of the 





Allelic Imbalance in GWAS loci: 
Each of these sites was compared to the loci identified by the GWAS study (Mirkov et al) 
to determine which sites overlapped GWAS loci. In this comparison, 62 sites, or 0.65% of the 
9470 sites, overlapped a GWAS locus. However, many of these sites overlapped the same locus, 
so a smaller number of sites overlapped unique GWAS loci. Two of these sites were further 
investigated, as they surrounded an interesting region in the genome (Figure 4).  
 
Figure 4: Allelic imbalance sites overlapping GWAS loci 
 
All allelic imbalance sites (p < 0.05) across the 10 samples that overlapped GWAS loci. Sites 
that were further investigated are in blue. The site in orange is present in two samples.  
 
 
Allelic imbalance in a regulatory region near the IL2RA gene: 
Sites at positions 6110925 and 6111622 on chromosome 10 were noted to be in a region 
that is influential to Crohn’s Disease. These sites are roughly 5000 bases downstream of the 
IL2RA gene, which is known to be significantly associated with Crohn’s Disease (Bouzid et al). 
The IL2RA gene codes for a receptor protein that detects the IL2 cytokine. The IL2 cytokine 
plays a central role in organizing the immune response, and may cause Ulcerative Colitis 
susceptibility (Parkes et al).  
The SNP at position 6110925 is in a CREBBP binding site. CREBBP is a protein which 
inhibits NFkB activity (McKay et al). NFkB has been documented as a key regulator in the 
chronic mucosal inflammation in Crohn’s Disease (Atreya et al). Additionally, each of these 
allelic imbalance sites encompass the transcription factor binding site of NFkB. Allelic 





The purpose of this analysis was to apply WASP’s mapping and Combined Haplotype 
Test pipelines to the 169 patient samples. After processing each of the samples, an analysis was 
performed on the 10 Crohn’s Disease samples with the highest number of allelic imbalance sites. 
In the future, we aim to perform similar analyses on sites from all of the samples across both the 
Crohn’s Disease and nonIBD groups.  
Allelic imbalance sites that are found in a single sample are not as significant as those 
found in multiple samples. Of the 9470 unique sites, 4.05% were found in at least 2 samples. 
While all sites are being analyzed, only sites common in multiple samples should be further 
investigated. In this smaller analysis of 10 samples, only a single site was common in two 
samples and overlapped a GWAS locus to merit further investigation. Therefore, we investigated 
other sites despite their only being present in a single sample.  
Two of the sites that overlapped GWAS loci were found in the regulatory region of the 
IL2RA gene, which plays a key role in the immune response, and has been associated with 
Crohn’s Disease. At these heterozygous sites, allelic imbalance could be influencing the 
inflammatory response in Crohn’s Disease by affecting transcription factor binding sites, due to 
differences in chromatin accessibility. By influencing whether a transcription factor could bind 
to the site, allelic imbalance could cause differential regulation of the target gene, IL2RA. 
Differential gene regulation would cause differential expression of this gene, which directly 
affects the inflammatory response.  
We are performing a parallel allelic imbalance analysis with RNA-seq data. While 
ATAC-seq shows sites of open chromatin in noncoding regions, RNA-seq looks directly at gene 
expression (Wang et al). The RNA-seq analysis is performed on 195 patient samples, many of 
which have ATAC-seq data. Some of the GWAS loci are in coding regions, and allelic 
imbalance sites of RNA-seq data may overlap these loci. Additionally, we can integrate allelic 
imbalance sites from the two datasets together to get a more comprehensive understanding of the 
mechanism behind gene expression pathways as they relate to Crohn’s Disease. If there is allelic 
imbalance in a promoter region, we can expect that the downstream gene variants, if 
heterozygous, will be expressed at different levels. That analysis can determine if there is a 
differential expression of the IL2RA gene in particular, as allelic imbalance sites have been 
overlapped with GWAS loci in surrounding regions.  
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